adverse drug reactions and quality of life with anti-hiv treatment
Not Applicable
Completed
- Conditions
- Health Condition 1: null- HIV positive
- Registration Number
- CTRI/2019/02/017398
- Lead Sponsor
- Dr Ruchika Irene Dillu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1.Diagnosed cases of HIV on ART, being treated on OPD basis.
2. Patient willing to participate in the study and give written informed consent after having been explained about the nature of the study
Exclusion Criteria
1.Patient having known hypersensitivity to any ART drug.
2.Patient not willing to participate in the study after having been explained about the nature of the study.
3.Seriously ill patients
4.CD4 count below 200µl/mm3 i.e., Stage 3 and stage 4 patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method asses adverse drug reactions with anti HIV drugsTimepoint: cross-sectional study(one point). on the day of subject enrollement irrespective of total duration for which patienthas been taking the drug.
- Secondary Outcome Measures
Name Time Method assess quality of life of patients with HIV positive and on ARTTimepoint: cross sectional study (one point). irrspective of duration for which patient has taken the drug, patient were assessed for Qol on the day of enrollement itself